Skip to main content
Caplight Logo









Resilient Lifescience

Resilient Lifescience

Private
Pittsburgh, PennsylvaniaHealthcare & Life Scienceshttps://resilient.bio/

Last Round

Grant

Sep 23, 2024

Est. Valuation

$5M

Total Funding Raised

$3.72M

Company Overview

Resilient Lifescience is a medical devices company developing a wearable patch that automatically detects and reverses an opioid overdose by delivering naloxone.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

opioid overdose reversalopioid overdose detectionwearable medical devicenaloxone auto-injectoroverdose preventionharm reduction technologywearable Narcannaloxonemedtechautomated drug deliveryvital sign monitoringwearable sensoraddiction technologyhealth IoTrecovery techopioid crisis technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resilient Lifescience Comparables

Compare Resilient Lifescience with similar companies based on industry and business-model similarity.

Resilient Lifescience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ZEM Life Device Company
91%
Rescue Biomedical LLC
86%
Ayuda Medical
76%

Resilient Lifescience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 23, 2024
AcceleratorDec 6, 2023
VC RoundFeb 7, 2023
Pre SeedMay 16, 2022

Key People

Founding team and executive leadership

Charlie Proctor

Co-founder CTO

Founding Team

Bradford Holden

Co-founder CEO

Founding Team

Resilient Lifescience Investors

Notable investors and investment history

Resilient Lifescience investors
InvestorRounds
AlphaLab HealthAccelerator
NIH RADxGrant
Richard King Mellon FoundationVC Round
Tau VenturesPre Seed
Chuangxin Innovation WorksAccelerator

Resilient Lifescience Filings

Explore SEC and related filing metadata, where available.

Resilient Lifescience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Resilient Lifescience's valuation, stock price, and market status.

Is Resilient Lifescience a public or private company?

Resilient Lifescience is a private company.

What is the current stock price of Resilient Lifescience?

Resilient Lifescience is a private company with no public stock price. No recent secondary market data is available.

How much is Resilient Lifescience worth (valuation)?

Resilient Lifescience's valuation is estimated at $5.0M based on funding round data.

Can I buy Resilient Lifescience stock?

Resilient Lifescience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Resilient Lifescience's last funding round?

Resilient Lifescience's most recent funding round was Grant on December 6, 2023.

Who are the main investors in Resilient Lifescience?

Key investors in Resilient Lifescience include Richard King Mellon Foundation.

Will Resilient Lifescience IPO soon?

No public IPO plans have been announced for Resilient Lifescience.

How can I track Resilient Lifescience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Resilient Lifescience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania
Employee Range4
Year Founded2022
Last FundingSep 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?